MAML2 and graft versus host disease: In contrast, SW620 DEGs were characterized by an enrichment in IFN and TNF signaling, ROS and NOTCH pathways (Jagged1, MAML2), but not in graft-versus-host disease or allograft rejection pathways (Fig. 1e, f).